Lumicks
LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.
Lumicks has raised €97M across 2 funding rounds from 1 investor, most recently a Debt round in Oct 2024. Based in Amsterdam, Netherlands; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€97M
€97,172,019
Funding rounds
2
Investors
1
distinct backers
Active since
2021-04
latest 2024-10
Funding by year
EUR raised per yearLumicks — funding by year — interactive chart.
Data table
| Lumicks — funding by year | |
|---|---|
| 2021 | €77M |
| 2024 | €20M |
Signals
High confidenceRaise-next likelihood7
base rate 45% for Debt
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-10-10 | Debt | €20M | European Investment Bank (EIB) | View deal → |
| 2021-04-21 | Other | €77M | — | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData